The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Blood Biomarkers to Detect Alzheimer Disease - Part 1
1:41
1:41
Play later
Play later
Lists
Like
Liked
1:41
In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1
1:12
1:12
Play later
Play later
Lists
Like
Liked
1:12
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Calium discuss the risk of developing dementia among patients with MCI at three or five-year time points. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209499By American Academy of Neurology
…
continue reading
Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease
3:07
3:07
Play later
Play later
Lists
Like
Liked
3:07
Dr. Jeff Ratliff discusses an exciting study in the world of deep brain stimulation for Parkinson disease. Show reference: https://www.nature.com/articles/s41591-024-03196-zBy American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse
2:03
2:03
Play later
Play later
Lists
Like
Liked
2:03
Dr. Tesha Monteith talks about the efficacy of atogepant for the preventive treatment of chronic migraine in participants with and without acute medication overuse. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209584By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Neuropsychological Profiles of Deployment-Related mTBI
3:05
3:05
Play later
Play later
Lists
Like
Liked
3:05
Dr. Stacey Clardy and Dr. Nicola de Souza discuss how to improve care in the clinic for these veterans and military service members. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209417By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Long-Term Dementia Risk in Parkinson Disease - Part 1
2:37
2:37
Play later
Play later
Lists
Like
Liked
2:37
In the first installment of this two-part series, Dr. Jeff Ratliff and Dr. Daniel Weintraub discuss the risks associated with the development of dementia in patients diagnosed with Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209699By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Interpreting DAT Imaging Results in the Clinical Context - Part 2
2:01
2:01
Play later
Play later
Lists
Like
Liked
2:01
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss why clinicians should be cautious when relying too much on dopaminergic imaging. Show reference: https://doi.org/10.1212/WNL.0000000000209453By American Academy of Neurology
…
continue reading
In part two of this two-part series, Dr. Tesha Monteith discusses the key features of long COVID. Show reference: https://doi.org/10.17226/27768By American Academy of Neurology
…
continue reading
In part one of this two-part series, Dr. Tesha Monteith discusses the 2024 National Academies of Sciences, Engineering, and Medicine formal definition of long COVID. Show reference: https://doi.org/10.17226/27768By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Interpreting DAT Imaging Results in the Clinical Context
1:37
1:37
Play later
Play later
Lists
Like
Liked
1:37
Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss the strengths of dopamine transporter imaging or DAT imaging in diagnosing patients with Parkinsonian disorders. Show references: https://doi.org/10.1212/WNL.0000000000209453By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1
2:33
2:33
Play later
Play later
Lists
Like
Liked
2:33
Dr. Dan Ackerman and Dr. Luciano A. Sposato discuss the topic of embolic stroke of undetermined sources and the controversies surrounding cardiac monitoring and anticoagulation. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209535By American Academy of Neurology
…
continue reading
Dr. Tesha Monteith provides an overview of the updated position statement on migraine prevention by the American Headache Society.By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core - Part 2
3:19
3:19
Play later
Play later
Lists
Like
Liked
3:19
In part two of this two-part series, Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the differences in treatment between American Stroke Centers and those in France. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398By American Academy of Neurology
…
continue reading
Dr. Meagan Seay discusses a relatively recently described but very interesting phenomenon called transient smartphone blindness. This is a phenomenon causing acute, painless, transient, monocular vision loss associated with smartphone use while lying down in the dark. Show reference: Transient Smartphone Blindness - EyeWiki…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core
2:17
2:17
Play later
Play later
Lists
Like
Liked
2:17
Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Ethical Landscape of Prodromal Parkinson Disease
2:13
2:13
Play later
Play later
Lists
Like
Liked
2:13
Dr. Jason Crowell and Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209522By American Academy of Neurology
…
continue reading
In the last episode of this three-part series, Dr. Jeff Ratliff discusses how to approach patients presenting with emergent rigidity and difficulty moving.By American Academy of Neurology
…
continue reading
In the second episode of this three-part series, Dr. Jeff Ratliff provides a rapid overview of hyperkinetic disorders that require urgent attention.By American Academy of Neurology
…
continue reading
In the first episode of this three-part series, Dr. Jeff Ratliff discusses a few key points to help recognize and initiate treatment for patients with movement disorder emergencies, focusing on the initial approach to these disorders. It is important to consider medications, labs, and imaging as part of the evaluation process.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Association of Prenatal Exposure to Antiseizure Medications
2:24
2:24
Play later
Play later
Lists
Like
Liked
2:24
Dr. Halley Alexander and Dr. Kimford Meador discuss perinatal exposure to anti-seizure medications and its effects on creativity and executive function in children. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209448By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tapping the Brakes on New Parkinson Disease Biological Staging
2:43
2:43
Play later
Play later
Lists
Like
Liked
2:43
Dr. Matthew Barrett and Dr. Michael S. Okun discuss the caution and deliberation needed in understanding Parkinson disease biomarkers. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820441By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2
3:16
3:16
Play later
Play later
Lists
Like
Liked
3:16
In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan. Show references: https://doi.org/10.1016/…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Large Language Models for Quality and Efficiency of Neurologic Care - Part 2
2:40
2:40
Play later
Play later
Lists
Like
Liked
2:40
In the final part of this two-part series, Dr. Andy Southerland and Dr. Lidia Moura discuss strategies on how clinicians can mitigate bias when using large language models. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209497By American Academy of Neurology
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency - Part 2
2:15
2:15
Play later
Play later
Lists
Like
Liked
2:15
Dr. Justin Abbatemarco, Dr. Michael R. Wilson, and Dr. John Pluvinage discuss their discovery of anti-CD320 antibodies in patients with neurologic manifestations of B12 deficiency and discuss the potential implications for diagnosis and treatment. Show reference: https://www.science.org/doi/10.1126/scitranslmed.adl3758…
…
continue reading